IMNN – imunon, inc. (US:NASDAQ)
Stock Stats
News
Imunon (NASDAQ:IMNN) had its "buy" rating reaffirmed by analysts at Brookline Capital Management.
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules [Yahoo! Finance]
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026 [Yahoo! Finance]
IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026
Form 8-K Imunon, Inc. For: Jan 07
Form 4 Imunon, Inc. For: Jan 02 Filed by: Bragg Kimberly
Form 4 Imunon, Inc. For: Jan 02 Filed by: Anwer Khursheed
Form 4 Imunon, Inc. For: Jan 02 Filed by: Fritz Frederick J.
Form 4 Imunon, Inc. For: Jan 02 Filed by: Eylward Susan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.